Document complet  |  Dérouler chapitre  |  Etendre sommaire  |  Version HTML imprimable
Use of the WHO Certification Scheme on the Quality of Pharmaceutical Products Moving in International Commerce - EDM Research Series No. 016
(1995; 156 pages) Voir le document au format PDF
Table des matières
Afficher le documentACKNOWLEDGMENTS
Afficher le documentPREFACE
Afficher le documentEXECUTIVE SUMMARY
Ouvrir ce répertoire et afficher son contenu1. INTRODUCTION
Afficher le document2. RATIONALE AND OBJECTIVE OF THE ASSESSMENT
Afficher le document3. ACTIVITIES UNDERTAKEN: Preparations and Method of Work
Ouvrir ce répertoire et afficher son contenu4. ANALYSIS OF RESULTS FROM IMPORTING COUNTRIES
Ouvrir ce répertoire et afficher son contenu5. ANALYSIS OF RESULTS FROM EXPORTING COUNTRIES
Afficher le document6. ANALYSIS OF RESULTS FROM INTERNATIONAL SUPPLY AGENCIES
Ouvrir ce répertoire et afficher son contenu7. SUMMARY ANALYSIS
Afficher le document8. CONCLUSIONS
Afficher le documentANNEX 1: Resolution adopted by the Twenty-second World Health Assembly
Afficher le documentANNEX 2 (a): Resolution Adopted by the Twenty-Eighth World Health Assembly
Afficher le documentANNEX 2 (b): Certificate of Pharmaceutical Product(S)1
Afficher le documentANNEX 3 (a): Resolution adopted by the Forty-first World Health Assembly
Afficher le documentANNEX 3 (b): Certificate of Pharmaceutical Product(s)1 (Proposed Layout)
Afficher le documentANNEX 4 (a): Proposed Guidelines on the WHO Certification Scheme on the Quality of Pharmaceutical Products Moving in International Commerce
Afficher le documentANNEX 4 (b): Certificate of a Pharmaceutical Product
Afficher le documentANNEX 4 (c): Statement of Licensing Status of Pharmaceutical Product(s) Model Statement of Licensing Status of Pharmaceutical Product(s)
Afficher le documentANNEX 4 (d): Manufacturer’s/Official Batch Certificate of a Pharmaceutical Product
Afficher le documentANNEX 5: Protocol for the Assessment of the Use of the WHO Certification Scheme by Importing Country
Afficher le documentANNEX 6: List of Participants in the Study
Afficher le documentANNEX 7: Protocol for the Assessment of the Use of the WHO Certification Scheme by Exporting Country
Afficher le documentANNEX 8: Protocol for the Assessment of the Use of the WHO Certification Scheme in an International Supply Organization
Afficher le documentANNEX 9: Study Instrument for Assessment of the WHO Certification Scheme by Importing Country
Ouvrir ce répertoire et afficher son contenuANNEX 10: Summaries of Mission Reports on the Assessment of the Use of the WHO Certification Scheme
Afficher le documentBACK COVER
 

2. RATIONALE AND OBJECTIVE OF THE ASSESSMENT

During the last two decades WHO has promoted the use of the WHO Certification Scheme particularly by importing countries of the developing world who, for various reasons, may be vulnerable to problems associated with pharmaceutical products that do not meet specifications. These countries often do not have the national laboratories required to verify the quality of drugs.

Since the introduction of the Scheme, there have been important changes in the nature and scope of the international market in pharmaceutical products. Many more countries are now involved in the export of drugs so that there is no longer a limited number of primary sources in a few major industrial countries. In addition, the opportunities for re-packaging and labelling have grown to further complicate the issuance of a Certificate of a Pharmaceutical Product by a national regulatory authority.

It has also become clear that the exact forms of the WHO Certification Scheme, as described above, have not yet been applied to most of the pharmaceutical products moving in international trade. When this is coupled with the serious problems of sub-standard drugs moving in international commerce, particularly to developing countries, it is clearly important to assess the practical application of the Certification Scheme.

The Action Programme on Essential Drugs (DAP), with the financial support of USAID's Office of Health, therefore, decided to carry out an independent assessment of the use of the Certification Scheme in drug procurement/supply systems and current mechanisms of drug quality assurance, in order to examine its effectiveness and enhance its wider use.

vers la section précédente
vers la section suivante
 
 
Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 1 décembre 2019